A PYMNTS Company

US: American Medical Association presents new data to oppose insurance mergers

By  |  September 21, 2016

New data presented on Wednesday shows the nation needs more competition in health insurance markets, and supports antitrust efforts to block the pending mergers among four of the nation’s biggest health insurance companies. Left unopposed, Anthem’s acquisition of Cigna and Aetna’s takeover of Humana would quash competition in insurance markets across 24 states according to newly updated market analyses released by the American Medical Association (AMA).

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    “The AMA analyses show that Anthem-Cigna and Aetna-Humana mergers would significantly compromise market competition in the health insurance industry and threaten health care access, quality and affordability,” said AMA President Andrew W. Gurman, M.D. “With existing competition in health insurance markets already at alarmingly low levels, federal and state antitrust officials have powerful reasons to block harmful mergers and foster a more competitive marketplace that will operate in patients’ best interests.”

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    The AMA analyses are intended to help federal and state regulators in their continuing effort to identify markets where mergers may cause competitive harm to the local health system.

    Full Content: Market Wired

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.